Table 1 Baseline clinical and pathological characteristics
No. patient (n = 34) | |
|---|---|
Age (y)a | 59 (28–84) |
Gender | |
Men | 21 (61.8%) |
Women | 13 (38.2%) |
BMI (kg/m2)a | 21.6 (18.4–25.8) |
ASA | |
I | 0 ( 0%) |
II | 19 ( 55.9%) |
III | 15 (44.1%) |
Pathological T stage | |
T1 | 1( 2.9%) |
T2 | 4 ( 11.8%) |
T3 | 11 ( 32.4%) |
T4 | 18(52.9%) |
Pathological N stage | |
N0 | 9(26.5%) |
N1 | 11 (32.4%) |
N2 | 14(41.1%) |
Pathological M stage | |
M0 | 34 (100%) |
M1 | 0 |